Specifically, the CHMP has backed conditional marketing authorisation for Ojemda (tovorafenib) as a monotherapy for children ...

Monitoring brain tumor progression is a complex balancing act between objective imaging and subjective clinical changes. In a ...

Nuvation Bio (NYSE:NUVB) executives highlighted the company’s first full year of commercial activity for IBTROZI and outlined late-stage development plans for safusidenib during the company’s ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...

Four mentored undergrad research projects from Western Kentucky University were selected for the 24th Posters-at-the-Capitol on March 5, 2026, in Frankfort's Capitol Annex building.

Nuvation Bio Inc. reports fourth-quarter and full-year 2025 financial results Monday after the market close, a pivotal report for the oncology company as it seeks to demonstrate sustained commercial ...

Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...

In 2015, Carl Manuel’s 29-year-old daughter Nicola was diagnosed with a brain tumour. Otherwise, fit and well, and training for a marathon, the diagnosis was a huge shock to her family.

Mahdi and his team found several communication problems. People often didn’t give the chatbots the necessary information to ...

Cancer remains one of the world’s most serious health threats, especially when it spreads beyond its original site. That ...

Social media influencers and supplement companies have stoked concerns, but experts say the issue is a lot more complicated.

Clinicians had attributed his worsening muscle weakness and diffuse pain to small-fiber neuropathy and chronic Lyme disease, but treatments including intravenous immunoglobulin and antibiotics ...